Cited 5 times in
Absence of neutralizing activity in serum 1 year after successful treatment with antivirals and recovery from MERS in South Korea
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 구남수 | - |
dc.contributor.author | 김정호 | - |
dc.contributor.author | 성혜 | - |
dc.contributor.author | 안진영 | - |
dc.contributor.author | 염준섭 | - |
dc.contributor.author | 정수진 | - |
dc.contributor.author | 최준용 | - |
dc.contributor.author | 최흔 | - |
dc.date.accessioned | 2019-09-20T07:38:33Z | - |
dc.date.available | 2019-09-20T07:38:33Z | - |
dc.date.issued | 2019 | - |
dc.identifier.issn | 2287-3651 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/170991 | - |
dc.description.abstract | We evaluated the neutralizing activity in serum from three patients >1 year after recovery from Middle East respiratory syndrome (MERS) associated with mild pneumonia treated with antivirals during the MERS outbreak in South Korea at 2015. The neutralizing activity in serum was measured by pseudovirus inhibition assays. Three-fold diluted serum of subjects showed only 9.7%, 10.3%, and 2.2% reductions in relative light units. So, significant neutralizing activity was not demonstrated in any sera of three patients with mild pneumonia >1 year after being successfully treated with antiviral agents and recovering from MERS coronavirus infection. | - |
dc.description.statementOfResponsibility | open | - |
dc.language | English | - |
dc.publisher | Korean Vaccine Society | - |
dc.relation.isPartOf | Clinical Experimental Vaccine Research | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.title | Absence of neutralizing activity in serum 1 year after successful treatment with antivirals and recovery from MERS in South Korea | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학교실) | - |
dc.contributor.googleauthor | Jun Yong Choi | - |
dc.contributor.googleauthor | Jin Ok Oh | - |
dc.contributor.googleauthor | Jin Young Ahn | - |
dc.contributor.googleauthor | Heun Choi | - |
dc.contributor.googleauthor | Jung Ho Kim | - |
dc.contributor.googleauthor | Hye Seong | - |
dc.contributor.googleauthor | Su Jin Jeong | - |
dc.contributor.googleauthor | Nam Su Ku | - |
dc.contributor.googleauthor | Joon-Sup Yeom | - |
dc.contributor.googleauthor | Jae-Phil Choi | - |
dc.identifier.doi | 10.7774/cevr.2019.8.1.86 | - |
dc.contributor.localId | A00189 | - |
dc.contributor.localId | A00902 | - |
dc.contributor.localId | A05140 | - |
dc.contributor.localId | A02267 | - |
dc.contributor.localId | A02353 | - |
dc.contributor.localId | A03638 | - |
dc.contributor.localId | A04191 | - |
dc.contributor.localId | A04227 | - |
dc.relation.journalcode | J00573 | - |
dc.identifier.eissn | 2287-366X | - |
dc.identifier.pmid | 30775355 | - |
dc.subject.keyword | Middle East respiratory syndrome coronavirus | - |
dc.subject.keyword | Neutralizing antibodies | - |
dc.subject.keyword | Serum | - |
dc.contributor.alternativeName | Ku, Nam Su | - |
dc.contributor.affiliatedAuthor | 구남수 | - |
dc.contributor.affiliatedAuthor | 김정호 | - |
dc.contributor.affiliatedAuthor | 성혜 | - |
dc.contributor.affiliatedAuthor | 안진영 | - |
dc.contributor.affiliatedAuthor | 염준섭 | - |
dc.contributor.affiliatedAuthor | 정수진 | - |
dc.contributor.affiliatedAuthor | 최준용 | - |
dc.contributor.affiliatedAuthor | 최흔 | - |
dc.citation.volume | 8 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 86 | - |
dc.citation.endPage | 88 | - |
dc.identifier.bibliographicCitation | Clinical Experimental Vaccine Research, Vol.8(1) : 86-88, 2019 | - |
dc.identifier.rimsid | 62638 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.